Comparing self-management of oral anticoagulant therapy with clinic management -: A randomized trial

被引:139
作者
Menéndez-Jándula, B
Souto, JC
Oliver, A
Montserrat, I
Quintana, M
Glch, I
Bonfill, X
Fontcuberta, J
机构
[1] Hosp Santa Creu & Sant Pau, Unitat Hemostasia & Trombosi, Barcelona 08025, Spain
[2] Fdn Puigvert, Barcelona, Spain
关键词
D O I
10.7326/0003-4819-142-1-200501040-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: control of oral anticoagulant treatment has been reported to be suboptimal, but previous studies suggest that patient self-management improves control. Objective: To compare the quality of control and the clinical outcomes of oral anticoagulant treatment in self-managed patients versus patients following conventional management. Design: Randomized, controlled trial. Setting: University-affiliated hospital in Spain. Patients: 737 patients with indications for anticoagulant treatment. Intervention: The self-management group (n = 368) received simple instructions for using a portable coagulometer weekly and self-adjusting treatment dose. The conventional management group (n = 369) received usual care in an anticoagulation clinic (monthly measurement and control of international normalized ratio [INR], managed by hematologists). Measurements: Percentage of INR values within the target range and major related complications. Results: The median follow-up period was 11.8 months (range, 0.3 to 16.9 months). The unadjusted percentages of in-range INRs were 58.6% in the self-management group and 55.6% in the conventional management group (difference, 3.0 percentage points [95% CI, 0.4 to 5.4 percentage points]). Twenty-seven patients (7.3%) in the conventional management group and 8 (2.2%) in the self-management group had major complications related to anticoagulant treatment. The unadjusted risk difference for major complications between groups was 5.1 percentage points (exact 95% CI, 1.7 to 8.5 percentage points). Fewer patients had minor hemorrhages in the self-management group (14.9%) than in the conventional management group (36.4%). Fifteen patients (4.1%) in the conventional management group and 6 (1.6%) in the self-management group died (unadjusted risk difference, 2.5 percentage points [exact 95% CI, 0.0 to 5.1 percentage points]). Limitations: The trial was performed at only 1 center and was not blinded. The dropout rate in the intervention group was 21%. Conclusions: Compared with conventional management by an anticoagulation clinic, self-management of oral anticoagulant treatment achieved a similar level of control. Of note, major complications and minor hemorrhages were less common in the self-management group.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 36 条
[31]   Self-management of oral anticoagulation:: long-term results [J].
Sawicki, PT ;
Gläser, B ;
Kleespies, C ;
Stubbe, J ;
Schmitz, N ;
Kaiser, T ;
Didjurgeit, U .
JOURNAL OF INTERNAL MEDICINE, 2003, 254 (05) :515-516
[32]   Self-managed anticoagulation: Results from a two-year prospective randomized trial with heart valve patients [J].
Sidhu, P ;
O'Kane, HO .
ANNALS OF THORACIC SURGERY, 2001, 72 (05) :1523-1527
[33]   Systematic review of studies of self-management of oral anticoagulation [J].
Siebenhofer, A ;
Berghold, A ;
Sawicki, PT .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) :225-232
[34]   Cost-effectiveness of self-managed anticoagulant therapy in Germany [J].
Taborski, U ;
Wittstamm, FJ ;
Bernardo, A .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (01) :103-107
[35]  
Watzke HH, 2000, THROMB HAEMOSTASIS, V83, P661
[36]   HOME PROTHROMBIN TIME MONITORING AFTER THE INITIATION OF WARFARIN THERAPY - A RANDOMIZED, PROSPECTIVE-STUDY [J].
WHITE, RH ;
MCCURDY, SA ;
VONMARENSDORFF, H ;
WOODRUFF, DE ;
LEFTGOFF, L .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (09) :730-737